THE COVID-19 HUMAN TRIALS BY ALGERNON TO BEGIN IN SOUTH KOREA

HIGHLIGHTS

• Algernon Pharmaceuticals Inc. has obtained permission to begin human trials of a medicine in South Korea.
• This medicine can protect lungs from the lasting damage that COVID-19 virus can cause.
• Many studies and research reports have confirmed the lung damage that even patients having recovered from coronavirus can suffer from.

Some researchers are working with....